These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 14597610)

  • 21. Antithymocyte globulin for patients with myelodysplastic syndrome.
    Molldrem JJ; Caples M; Mavroudis D; Plante M; Young NS; Barrett AJ
    Br J Haematol; 1997 Dec; 99(3):699-705. PubMed ID: 9401087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
    Deeg HJ; Jiang PY; Holmberg LA; Scott B; Petersdorf EW; Appelbaum FR
    Leuk Res; 2004 Nov; 28(11):1177-80. PubMed ID: 15380342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunosuppressive treatment of the myelodysplastic syndrome].
    Larsen MS; Hasselbalch HC
    Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.
    Aivado M; Rong A; Stadler M; Germing U; Giagounidis A; Strupp C; Novotny J; Josten KM; Kobbe G; Hildebrandt B; Gattermann N; Aul C; Haas R; Ganser A
    Eur J Haematol; 2002 Apr; 68(4):210-6. PubMed ID: 12071936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of T-lymphocyte clonal dominance in patients with myelodysplastic syndrome responsive to immunosuppression.
    Kochenderfer JN; Kobayashi S; Wieder ED; Su C; Molldrem JJ
    Blood; 2002 Nov; 100(10):3639-45. PubMed ID: 12393644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome.
    Bevans MF; Shalabi RA
    Clin J Oncol Nurs; 2004 Aug; 8(4):377-82. PubMed ID: 15354924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-thymocyte globulin in haematology: Recent developments.
    Siddiqui S; Cox J; Herzig R; Palaniyandi S; Hildebrandt GC; Munker R
    Indian J Med Res; 2019 Sep; 150(3):221-227. PubMed ID: 31719292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myelodysplasia.
    Dansey R
    Curr Opin Oncol; 2000 Jan; 12(1):13-21. PubMed ID: 10687724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical immunosuppression with antilymphocyte globulin.
    Stiller CR
    Can Med Assoc J; 1976 Dec; 115(12):1190-1. PubMed ID: 793703
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypocellular myelodysplasia.
    Sloand EM
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):347-60. PubMed ID: 19327588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
    Miyata A; Yasuda Y; Fujii S; Kikuchi T
    Rinsho Ketsueki; 2002 Oct; 43(10):911-7. PubMed ID: 12462026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
    Biesma DH; van den Tweel JG; Verdonck LF
    Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome.
    Steensma DP; Dispenzieri A; Moore SB; Schroeder G; Tefferi A
    Blood; 2003 Mar; 101(6):2156-8. PubMed ID: 12411290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron chelation therapy for patients with myelodysplastic syndrome.
    Yeh SP; Yang YS; Yao CY; Peng CT
    Hemoglobin; 2009; 33(5):339-45. PubMed ID: 19814680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of anemia associated with myelodysplastic syndrome.
    Hellström-Lindberg E
    Semin Hematol; 2005 Apr; 42(2 Suppl 1):S10-3. PubMed ID: 15846579
    [No Abstract]   [Full Text] [Related]  

  • 36. Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.
    Bonifazi F; Olivieri J; Sessa M; Dan E; Sinigaglia B; Rizzi S; Motta MR; Bontadini A; Ulbar F; Giudice V; Papayannidis C; Curti A; Chiereghin A; Lazzarotto T; Cavo M; Arpinati M
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2450-2458. PubMed ID: 30026107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
    [No Abstract]   [Full Text] [Related]  

  • 38. Antilymphocyte globulin and its use in skin diseases.
    Barrett AJ
    Int J Dermatol; 1977 Nov; 16(9):738-9. PubMed ID: 144706
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recent progress in the diagnosis and treatment of aplastic anemia in children].
    Kojima S
    Rinsho Ketsueki; 2009 Oct; 50(10):1444-52. PubMed ID: 19915353
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental and clinical administration of cytotoxic antilymphocyte serum and antilymphocyte globulin in homologous skin transplantation].
    Spasokukots'kii IuO; Gorodets'ka SF; Timoshenko IuG
    Fiziol Zh; 1971; 17(3):341-5. PubMed ID: 4118041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.